| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 15, 2007
Accepted on December 10, 2007
Endocrine Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, Mattapan Community Health Center, Mattapan, Massachusetts, Quest Diagnostics Nichols Institute, San Juan Capistrano, California
* To whom correspondence should be addressed. E-mail: mfholick{at}bu.edu.
Context Two reports suggested that vitamin D2 is less effective than vitamin D3 in maintaining vitamin D status.
Objective Determine whether vitamin D2 was less effective than vitamin D3 in maintaining serum 25-hydroxyvitamin D levels or increased the catabolism of 25-hydroxyvitamin D3.
Subjects and Design This was a randomized, placebo-controlled, double-blinded study of healthy adults ages 18–84 years who received either placebo, 1,000 IU of vitamin D3, 1,000 IU of vitamin D2, or 500 IU of vitamin D2 plus 500 IU of vitamin D3 daily for 11 weeks at the end of the winter.
Results Sixty percent of the healthy adults were vitamin D deficient at the start of the study. The circulating levels of 25-hydroxyvitamin D (mean ± SD) increased to the same extent in the groups that received 1,000 IU daily as vitamin D2 (baseline 16.9 ± 10.5 ng/ml; 11 weeks 26.8 ± 9.6 ng/ml); vitamin D3 (baseline 19.6 ± 11.1 ng/ml; 11 weeks 28.9 ± 11.0 ng/ml) or a combination of 500 IU vitamin D2 and 500 IU vitamin D3, (baseline 20.2 ± 10.4 ng/ml; 11 weeks 28.4 ± 7.7 ng/ml). The 25-hydroxyvitamin D3 levels did not change in the group that received 1,000 IU vitamin D2 daily. 1,000 IU of vitamin D2 or vitamin D3 did not raise 25-hydroxyvitamin D levels in vitamin D deficient subjects above 30 ng/ml.
Conclusion 1,000 IU of vitamin D2 daily was as effective as 1,000 IU of vitamin D3 in maintaining serum 25-hydroxyvitamin D levels and did not negatively influence serum 25-hydroxyvitamin D3 levels. Therefore, vitamin D2 is equally as effective as vitamin D3 in maintaining 25-hydroxyvitamin D status.
This article has been cited by other articles:
![]() |
I. Cantor Shedding Light on Vitamin D and Integrative Oncology Integr Cancer Ther, June 1, 2008; 7(2): 81 - 89. [Abstract] [PDF] |
||||
![]() |
Vitamin D2 vs. Vitamin D3 Supplementation -- Does It Matter? Journal Watch (General), March 25, 2008; 2008(325): 2 - 2. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |